COMPANY

Shape Memory Medical

HQ: San Jose, CA source · shapemem.com ↗ · West Coast

Location: San Jose, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Abdominal Aortic Aneurysm Aortic Dissection Peripheral Vascular Embolization Ruptured or Unruptured Cerebral Aneurysms False Lumen Embolization System, IMPEDE-FX RapidFill IMPEDE-FX Embolization Plug IMPEDE-FX RapidFill Implants IMPEDE, IMPEDE-FX or IMPEDE-FX RapidFill TrelliX Embolic Coil System

8Trials (company is sponsor)

Funding and NIH signals

SEC Form D raise Raised $6.91M in debt securities (Form D filed Jul 16, 2026; amended Jul 31, 2026). SEC Form D 0001630786-26-000002 (Jul 16, 2026)
Evidence (1 event)
- Jul 16, 2026 · SEC Form D 0001630786-26-000002
  Name of Issuer: Shape Memory Medical Inc.; CIK: 1630786; Address: San Jose, CA; Submission type: D; Filing date: 2026-07-16; Industry Group: Other Health Care; Date of First Sale: 2026-07-02; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 6724900; Federal exemptions: 06b || Name of Issuer: Shape Memory Medical Inc.; CIK: 1630786; Address: San Jose, CA; Submission type: D/A; Filing date: 2026-07-31; Industry Group: Other Health Care; Date of First Sale: 2026-07-02; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 6912400; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

Raise Undisclosed round · $38M · announced Mar 5, 2024 Company release ↗
Source quote
- Mar 5, 2024 · Company release ↗
  “Shape Memory Medical Completes $38 Million in Financing to Advance Endovascular Embolization”

Raises announced in these releases: $38M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Timeline

Oct 1, 2026 Trial start Not phased (device or behavioral study): False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_FRA) source ↗
Apr 1, 2026 Trial start Not phased (device or behavioral study): False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_CHL) source ↗
Feb 24, 2026 Trial start Not phased (device or behavioral study): False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study source ↗
Apr 5, 2024 Trial start Not phased (device or behavioral study): AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion source ↗
Mar 5, 2024 Raise Undisclosed round · $38M source ↗
Jul 13, 2021 Trial start Not phased (device or behavioral study): Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks - Netherlands source ↗
Sep 9, 2020 Trial start Not phased (device or behavioral study): Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks source ↗
Jul 9, 2019 Trial start —: IMPEDE and IMPEDE-FX Embolization Plug Registry source ↗
Nov 21, 2018 Trial start Not phased (device or behavioral study): Aneurysm Packing With the Expandable TrelliX Coil System - A Prospective Safety Study source ↗

Upcoming milestones

Jan 4, 2027 (ESTIMATED) · Not phased · False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_FRA) · NCT06740721
Feb 15, 2027 (ESTIMATED) · Not phased · False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study · NCT06550986
Apr 1, 2027 (ESTIMATED) · Not phased · False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_CHL) · NCT07387250
2027-07 (ESTIMATED) · Not phased · AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion · NCT06029660

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 8

Record	Title	Phase	Status	Start	Primary completion
NCT06029660	AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion	Not phased (device or behavioral study)	Active, not recruiting	Apr 5, 2024	2027-07 (estimated)
NCT06550986	False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study	Not phased (device or behavioral study)	Recruiting	Feb 24, 2026	Feb 15, 2027 (estimated)
NCT07387250	False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_CHL)	Not phased (device or behavioral study)	Not yet recruiting	Apr 1, 2026	Apr 1, 2027 (estimated)
NCT06740721	False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_FRA)	Not phased (device or behavioral study)	Not yet recruiting	Oct 1, 2026	Jan 4, 2027 (estimated)
NCT04044443	IMPEDE and IMPEDE-FX Embolization Plug Registry	Not listed	Active, not recruiting	Jul 9, 2019	Aug 30, 2025 (actual)
NCT04227054	Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks	Not phased (device or behavioral study)	Active, not recruiting	Sep 9, 2020	Aug 30, 2023 (actual)
NCT03988062	Aneurysm Packing With the Expandable TrelliX Coil System - A Prospective Safety Study	Not phased (device or behavioral study)	Completed	Nov 21, 2018	May 31, 2021 (actual)
NCT04751578	Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks - Netherlands	Not phased (device or behavioral study)	Active, not recruiting	Jul 13, 2021	Apr 13, 2022 (actual)